Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

1.93USD
14 Dec 2018
Change (% chg)

$-0.02 (-1.03%)
Prev Close
$1.95
Open
$1.93
Day's High
$1.93
Day's Low
$1.93
Volume
100
Avg. Vol
78,208
52-wk High
$6.94
52-wk Low
$1.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.46 -0.904
Jun '18 0.85 -0.439
Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.605
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.69 1.02 0.50 1.60
Quarter Ending Mar-19 2 0.90 1.00 0.80 1.50
Year Ending Dec-18 7 9.62 10.06 9.34 5.67
Year Ending Dec-19 7 18.03 30.40 7.00 18.24
Earnings (per share)
Quarter Ending Dec-18 5 -0.32 -0.22 -0.36 -0.57
Quarter Ending Mar-19 2 -0.34 -0.31 -0.36 -0.42
Year Ending Dec-18 7 -2.09 -1.95 -2.19 -2.31
Year Ending Dec-19 7 -1.14 -0.74 -1.46 -2.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 50.61 49.58 6.22
Price to Book (MRQ) 0.46 10.17 5.20
Price to Tangible Book (MRQ) 6.16 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 61.24 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.12 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -13.83 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.69 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -8.57 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 3.77 3.44 3.10
LT Debt to Equity (MRQ) 0.44 18.69 11.49
Total Debt to Equity (MRQ) 0.44 31.36 16.03
Interest Coverage (TTM) -2.14 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -290.58 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -987.15 -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -991.86 -185.00 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -1,003.38 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -982.39 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 101,814 7,649,006 873,053,182
Net Income/Employee (TTM) -1,000,203 653,334 103,483,965
Receivable Turnover (TTM) 0.73 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.07 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.01 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -87.80 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -88.10 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 47 98
13 Week -20.95 -24.80 36 94
26 Week -24.27 -30.03 52 98
52 Week 15.92 -1.75 99 68
YTD 39.26 22.30 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.97%
# of Holders: 55
Total Shares Held: 38,158,802
3 Mo. Net Change: 14,865,641
# New Positions: 15
# Closed Positions: 13
# Increased Positions: 34
# Reduced Positions: 23
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.